Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety-Reference-Cited by-同舟云学术

Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety

Published:2022-03 Issue: Volume:Volume 15 Page:1205-1218
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Qu Jian^ORCID,Qi Ting-Ting,Qu Qiang,Long Wen-Ming^ORCID,Chen Ying,Luo Yue,Wang Ying

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference37 articles.

1. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae

2. World Health Organization. Critically Important Antimicrobials for Human Medicine – 5th Rev. Geneva: World Health OrganizationLicence: CC BY‐NCSA3.0 IGO; 2017.

3. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018

4. Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and safety of polymyxin B versus tigecycline combination therapy for pneumonia of carbapenem-resistant Klebsiella pneumoniae : a retrospective cohort study;Annals of Medicine;2024-09-06

2. Factors affecting the effectiveness and safety of polymyxin B in the treatment of Gram-negative bacterial infections: A meta-analysis of 96 articles;International Journal of Antimicrobial Agents;2024-09

3. Clinical Effectiveness and Safety of Colistin Sulphate in Treating Infections Caused by Carbapenem-Resistant Organisms and Analysis of Influencing Factors;Infection and Drug Resistance;2024-09

4. Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study;Infection;2024-06-17

5. Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections;Pharmaceutics;2024-01-03